Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Commission A Key Element Of Health Care Reform Legislation, Administration Insists

This article was originally published in The Pink Sheet Daily

Executive Summary

During a Nov. 25 briefing, White House officials reinforced the administration's support for an advisory panel focused on reining in Medicare costs on an ongoing basis and in a way that minimizes the political fallout from those cuts.
Advertisement

Related Content

AARP Lobbies Against Independent Medicare Advisory Board As Conferencing Begins On Health Care Bill
AARP Lobbies Against Independent Medicare Advisory Board As Conferencing Begins On Health Care Bill
Comparative Effectiveness Research Will Produce Near-Term Delivery Reform - OMB's Orszag
Comparative Effectiveness Research Will Produce Near-Term Delivery Reform - OMB's Orszag
Part D Price Negotiation Surfaces Again? IMAC Proposal Needs Close Read
Part D Price Negotiation Surfaces Again? IMAC Proposal Needs Close Read

Topics

Advertisement
UsernamePublicRestriction

Register

PS068808

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel